![Jonathan Burgin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Burgin
Chief Executive Officer at BioCancell Therapeutics, Inc.
Network origin in Jonathan Burgin first degree
Entity | Entity type | Industry | |
---|---|---|---|
PricewaterhouseCoopers International Ltd.
![]() PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom.
39
| Private Company | Miscellaneous Commercial Services | 39 |
Extinct | Biotechnology | 29 | |
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.
13
| Subsidiary | Biotechnology | 13 |
8
| Public Company | Packaged Software | 8 |
Public Company | Medical Specialties | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan Burgin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree | |
CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Executive Officer Director/Board Member Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO Director/Board Member | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chairman Comptroller/Controller/Auditor Consultant / Advisor | |
Technion-Israel Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Clal Biotechnology Industries Ltd. (Venture Capital)
![]() Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Chief Executive Officer Chief Executive Officer President Director of Finance/CFO | |
CureTech Ltd.
![]() CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member | |
UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman Chairman Director/Board Member Director/Board Member | |
Bar-Ilan University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Chief Tech/Sci/R&D Officer Undergraduate Degree Graduate Degree | |
MEDIWOUND LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Comptroller/Controller/Auditor | |
Campus Bio Management Ltd.
![]() Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Saifun Semiconductors Ltd.
![]() Saifun Semiconductors Ltd. SemiconductorsElectronic Technology Saifun Semiconductors Ltd. develops, designs, licenses, manufactures and markets non-volatile memory solutions. It offers process design and installation, data, code and embedded product design, card design, production support, and compliance services. The company was founded by Boaz Eitan in 1996 and is headquartered in Netanya, Israel. | Semiconductors | Director/Board Member Director/Board Member | |
ROBOGROUP T.E.K. LTD. | Packaged Software | Director of Finance/CFO Comptroller/Controller/Auditor | |
State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Arison Investments Ltd.
![]() Arison Investments Ltd. Financial ConglomeratesFinance Arison Investments Ltd. provides investment services. The company was founded by Ted Arison in 1991 and is headquartered in Tel Aviv, Isreal. | Financial Conglomerates | Founder Portfolio Manager-Equities | |
FRESH TRACKS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
BANK HAPOALIM B.M. | Major Banks | Chairman Corporate Officer/Principal | |
Avraham Pharmaceuticals Ltd.
![]() Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
BIOLIGHT LIFE SCIENCES LTD. | Medical Specialties | Director/Board Member Comptroller/Controller/Auditor | |
New York University | College/University | Corporate Officer/Principal Undergraduate Degree | |
SCINAI IMMUNOTHERAPEUTICS LTD. | Pharmaceuticals: Other | Director/Board Member Comptroller/Controller/Auditor | |
THESEUS PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The University of North Carolina at Charlotte | College/University | Graduate Degree Undergraduate Degree | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Corporate Officer/Principal Masters Business Admin | |
Weizmann Institute of Science | College/University | Director of Finance/CFO Doctorate Degree | |
PLASTO-CARGAL GROUP LTD | Containers/Packaging | Director/Board Member Comptroller/Controller/Auditor | |
Brickell Subsidiary, Inc.
![]() Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Director/Board Member Founder | |
Concord Venture Management Ltd.
![]() Concord Venture Management Ltd. Investment ManagersFinance Concord Venture Management Ltd. (Concord) is a venture capital firm founded in 1992 by Yair Safrai and Matty Karp. The firm is headquartered in Herzelia, Israel. | Investment Managers | Founder Private Equity Investor | |
UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
eXIthera Pharmaceuticals, Inc.
![]() eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Anatomy Medical Technology Fund
![]() Anatomy Medical Technology Fund Investment ManagersFinance Anatomy Medical Technology Fund invests in companies located in Israel. The fund targets companies operating in the fields of medical technology. It provides financing for seed and early stage capital requirements. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
University of Bristol | College/University | Undergraduate Degree Undergraduate Degree | |
Danforth Advisors LLC
![]() Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Biomedical Investments
![]() Biomedical Investments Investment ManagersFinance Biomedical Investments operates as a private investment company. It focuses its investments on start-ups with breakthrough technologies, applicable in emerging therapeutic segments. The company was founded in 1997 and is headquartered in Tel-Aviv, Israel. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
TransPharma Medical Ltd.
![]() TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member Chairman | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
BEYOND AIR, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
Yeda Research & Development Co. Ltd.
![]() Yeda Research & Development Co. Ltd. Investment ManagersFinance Yeda Research & Development Co. Ltd. engages in development of natural science and services. It covers broad of spectrum including: biotechnology, pharmaceuticals and diagnostics, bioinformatics, proteomics, biomatics and system biology, medical devices, renewable energy, bio fuels, clean technology and environmental sciences, agricultural and plants genetics, chemistry and nanotechnology, physics and electro-optics, mathematics and computer science. The company is headquartered in Rehovot, Israel. | Investment Managers | Chief Executive Officer Chief Executive Officer |
Statistics
International
Israel | 28 |
United States | 22 |
Australia | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 17 |
Finance | 9 |
Commercial Services | 3 |
Technology Services | 3 |
Operational
Director/Board Member | 386 |
Corporate Officer/Principal | 174 |
Chairman | 85 |
Comptroller/Controller/Auditor | 80 |
Director of Finance/CFO | 77 |
Most connected contacts
Insiders | |
---|---|
Joseph Ginossar | 54 |
Benedict James Smith | 33 |
Stephen Hoffman | 33 |
Ofer Gonen | 31 |
Benad Goldwasser | 30 |
Aharon Schwartz | 29 |
David Schlachet | 28 |
Ruth Alon | 27 |
Michael Weiss | 25 |
Stephen DiPalma | 24 |
Ofer Goldberg | 23 |
Ruben Krupik | 23 |
Shlomo Kalish | 21 |
Michael Wichterich | 20 |
Isaac Kohlberg | 20 |
- Stock Market
- Insiders
- Jonathan Burgin
- Company connections